Categories: Top News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Hywin Holdings Ltd. – HYW

NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Hywin Holdings Ltd. (“Hywin” or the “Company”) (NASDAQ: HYW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Hywin and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On December 14, 2023, Hywin disclosed that redemption issues had been reported on certain asset-backed products previously distributed by the Company with clients demanding repayment from the Company. Hywin stated that it would be conducting an internal investigation.

On this news, Hywin’s American depositary receipt (“ADR”) price fell $0.53 per ADR, or 16%, to close at $2.77 per ADR on December 14, 2023.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

GlobeNewswire

GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Recent Posts

Lost Money on Zynex, Inc.(ZYXI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in…

31 minutes ago

Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences Holdings, Inc.(MRVI) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in…

33 minutes ago

Contact Levi & Korsinsky by May 12, 2025 Deadline to Join Class Action Against Geron Corporation (GERN)

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in…

33 minutes ago

Malignant Pleural Mesothelioma Market Poised for Growth Across the 7MM During the Study Period (2020–2034) Amid Advances in Immunotherapy and Targeted Drugs | DelveInsight

The malignant pleural mesothelioma market is poised for steady growth during the forecast period (2025–2034).…

33 minutes ago

This website uses cookies.